{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:42:30Z","timestamp":1767872550513,"version":"3.49.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Bladder cancer (BLCA) is a highly heterogeneous malignancy with an unpredictable prognosis. Tumour progression is closely linked to the complex tumour microenvironment (TME), particularly the role of epithelial cells. This study aims to identify key epithelial cell-derived signature genes driving tumour progression, construct a reliable prognostic model, and further explore the biological functions of a pivotal gene,\n                      <jats:italic>OAS1<\/jats:italic>\n                      , in BLCA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Single-cell RNA sequencing (scRNA-seq) data from public cohorts were analyzed to identify epithelial cell subpopulations and delineate their malignant progression trajectory. Genes significantly associated with this progression were identified through pseudotime analysis. Bulk RNA-seq and clinical data from The Cancer Genome Atlas (TCGA) BLCA cohort were utilized for least absolute shrinkage and selection operator (LASSO) Cox regression to build a prognostic risk model. The model\u2019s predictive efficacy was validated in an independent Gene Expression Omnibus (GEO) cohort. Furthermore,\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments including CCK-8, transwell, and wound healing assays were conducted to investigate the impact of OAS1 on the proliferation, migration, and invasion capabilities of BLCA cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      scRNA-seq analysis revealed a distinct epithelial cell subpopulation with high tumor-suppressive activity. A four-gene signature associated with tumor progression was successfully constructed into a prognostic model. Patients in the high-risk group exhibited significantly poorer overall survival in both the TCGA and validation cohorts. Multivariate Cox analysis confirmed the model as an independent prognostic factor. The risk score was significantly correlated with immune infiltration patterns and response to immunotherapy. Among the signature genes,\n                      <jats:italic>OAS1<\/jats:italic>\n                      was identified as a critical factor.\n                      <jats:italic>In vitro<\/jats:italic>\n                      functional experiments demonstrated that knockdown of\n                      <jats:italic>OAS1<\/jats:italic>\n                      markedly promoted the proliferation, migration, and invasion of BLCA cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We established a novel prognostic model for BLCA based on epithelial cell tumor progression-associated genes, which serves as a robust predictor for patient outcomes and immunotherapeutic responsiveness. Our findings further highlight\n                      <jats:italic>OAS1<\/jats:italic>\n                      as a key gene that suppresses the aggressive phenotypes of BLCA cells, suggesting it is a potential therapeutic target. This study provides valuable insights for precise prognosis and treatment stratification of BLCA patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2025.1716130","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:43:42Z","timestamp":1767861822000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel prognostic model based on epithelial cell progression genes identifies OAS1 as a suppressor of bladder cancer aggressiveness"],"prefix":"10.3389","volume":"12","author":[{"given":"Xu","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuerui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanbiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangbin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1016\/s0021-9258(18)61434-6","article-title":"Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells","volume":"262","author":"Chebath","year":"1987","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e40127","DOI":"10.1371\/journal.pone.0040127","article-title":"A MicroRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer","volume":"7","author":"Chiariotti","year":"2012","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1093\/nar\/gkaa513","article-title":"Human OAS1 activation is highly dependent on both RNA sequence and context of activating RNA motifs","volume":"48","author":"Conn","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"20210106","DOI":"10.1002\/EXP.20210106","article-title":"Recent advances in overcoming barriers to cell-based delivery systems for cancer immunotherapy","volume":"2","author":"Ding","year":"2022","journal-title":"Explor. (Beijing)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur. Urol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN guidelines\u00ae insights: bladder cancer, version 2.2022","volume":"20","author":"Flaig","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"B8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20150213","article-title":"HOXB5 induces invasion and migration through direct transcriptional up-regulation of \u03b2-catenin in human gastric carcinoma","volume":"472","author":"Hong","year":"2015","journal-title":"Biochem. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/j.1460-2075.1987.tb02364.x","article-title":"Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies","volume":"6","author":"Hovanessian","year":"1987","journal-title":"EMBO J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1207081","DOI":"10.3389\/fonc.2023.1207081","article-title":"Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/ijms23010450","article-title":"Wnt\/\u03b2-Catenin signaling contributes to paclitaxel resistance in bladder cancer cells with cancer stem cell-like properties","volume":"23","author":"Jim\u00e9nez-Guerrero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/pl00000644","article-title":"Gene structure and function of the 2\u2032-5\u2032-oligoadenylate synthetase family","volume":"57","author":"Justesen","year":"2024","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"B13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/dgd.12199","article-title":"Roles of Hoxb5 in the development of vagal and trunk neural crest cells","volume":"57","author":"Kam","year":"2015","journal-title":"Dev. Growth and Differ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019101573","article-title":"Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death","volume":"39","author":"Kondratova","year":"2020","journal-title":"EMBO J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.hoc.2021.02.006","article-title":"Contemporary and emerging approaches to bladder-preserving trimodality therapy for muscle-invasive bladder cancer","volume":"35","author":"Konieczkowski","year":"2021","journal-title":"Hematology\/Oncology Clin. N. Am."},{"key":"B17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.7150\/ijbs.11431","article-title":"HOXB5 promotes the proliferation and invasion of breast cancer cells","volume":"11","author":"Lee","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20230025","DOI":"10.1002\/inmd.20230025","article-title":"Anti-angiogenic therapy enhances cancer immunotherapy: mechanism and clinical application","volume":"2","author":"Li","year":"2024","journal-title":"Interdiscip. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"20220136","DOI":"10.1002\/EXP.20220136","article-title":"Alteration of chromatin high-order conformation associated with oxaliplatin resistance acquisition in colorectal cancer cells","volume":"3","author":"Li","year":"2023","journal-title":"Explor. (Beijing)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41420-021-00419-x","article-title":"The long noncoding RNA TINCR promotes breast cancer cell proliferation and migration by regulating OAS1","volume":"7","author":"Lu","year":"2021","journal-title":"Cell Death Discov."},{"key":"B22","doi-asserted-by":"publisher","first-page":"944194","DOI":"10.3389\/fonc.2022.944194","article-title":"Overexpression of OAS1 is correlated with poor prognosis in pancreatic cancer","volume":"12","author":"Lu","year":"2022","journal-title":"Front. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10585-014-9667-0","article-title":"Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines","volume":"31","author":"Marino","year":"2014","journal-title":"Clin. and Exp. Metastasis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrurol.2014.130","article-title":"Landmarks in non-muscle-invasive bladder cancer","volume":"11","author":"Mertens","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/jpm13050756","article-title":"Precision medicine in bladder cancer: present challenges and future directions","volume":"13","author":"Mohanty","year":"2023","journal-title":"J. Personalized Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e20230047","DOI":"10.1002\/inmd.20230047","article-title":"CAR-T-cell products in solid tumors: progress, challenges, and strategies","volume":"2","author":"Qian","year":"2024","journal-title":"Interdiscip. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2020.00012","article-title":"Identification and validation of an individualized prognostic signature of bladder cancer based on seven immune related genes","volume":"11","author":"Qiu","year":"2020","journal-title":"Front. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"25535","DOI":"10.1074\/jbc.274.36.25535","article-title":"The nature of the catalytic domain of 2\u2032-5\u2032-Oligoadenylate synthetases","volume":"274","author":"Sarkar","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/1043-6618(89)90132-1","article-title":"Induction of 2\u2032-5\u2032 oligoadenylate synthetase by 17\u03b2-oestradiol in a human breast cancer cell line","volume":"21","author":"Silvestro","year":"1989","journal-title":"Pharmacol. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0167-4889(86)90164-3","article-title":"Effect of estrogen administration on rat liver 2-5A synthetase activity","volume":"887","author":"Smekens","year":"1986","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Cell Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3389\/fonc.2020.01300","article-title":"A prognostic nomogram combining immune-related gene signature and clinical factors predicts survival in patients with lung adenocarcinoma","volume":"10","author":"Song","year":"2020","journal-title":"Front. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101071","DOI":"10.1016\/j.neo.2024.101071","article-title":"Doxorubicin resistance involves modulation of interferon signaling, transcriptional bursting, and gene co-expression patterns of U-ISGF3-related genes","volume":"58","author":"Trzaskoma","year":"2024","journal-title":"Neoplasia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1590\/s1678-77572011000200008","article-title":"HOXB5 expression in oral squamous cell carcinoma","volume":"19","author":"Tucci","year":"2011","journal-title":"J. Appl. Oral Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e20815","DOI":"10.1371\/journal.pone.0020815","article-title":"HOXB5 cooperates with NKX2-1 in the transcription of human RET","volume":"6","author":"Uversky","year":"2011","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3892\/or.2020.7772","article-title":"HSH2D contributes to methotrexate resistance in human T-cell acute lymphoblastic leukaemia","volume":"44","author":"Wang","year":"2020","journal-title":"Oncol. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12890-024-03206-3","article-title":"Prognostic value and molecular mechanisms of OAS1 in lung adenocarcinoma","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3724\/zdxbyxb-2023-0343","article-title":"Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis","volume":"53","author":"Yin","year":"2025","journal-title":"J. Zhejiang Univ. Med. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12957-018-1475-6","article-title":"Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer","volume":"16","author":"Yu","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12885-020-07034-6","article-title":"Prognostic characterization of OAS1\/OAS2\/OAS3\/OASL in breast cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0378-1119(03)00753-4","article-title":"Characterization of AOC2 gene encoding a copper-binding amine oxidase expressed specifically in retina","volume":"318","author":"Zhang","year":"2003","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3727\/096504017x14900530835262","article-title":"Knockdown of homeobox B5 (HOXB5) inhibits cell proliferation, migration, and invasion in non-small cell lung cancer cells through inactivation of the Wnt\/\u03b2-Catenin pathway","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"39682","DOI":"10.1038\/s41598-025-23277-4","article-title":"The expression signature, prognostic significance and immune cell infiltration of the OAS gene family in gastric cancer","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1002\/ctm2.497","article-title":"Tumor\u2010derived exosomal BCYRN1 activates WNT5A\/VEGF\u2010C\/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer","volume":"11","author":"Zheng","year":"2021","journal-title":"Clin. Transl. Med."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2025.1716130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:43:44Z","timestamp":1767861824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2025.1716130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":44,"alternative-id":["10.3389\/fmolb.2025.1716130"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2025.1716130","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1716130"}}